2021 CANA Annual Conference

10:00-10:15

Opening Remarks

10:15-10:45

Migraine update

10:45-11:15

PD update

Moderator: Lin Zhang, MD, PhD, FAAN
Professor of Neurology and Neurological Surgery Department of Neurology, UC Davis School of Medicine, Sacramento, CA

11:45 -12:00

Epilepsy update
Speaker: Charles Wang MD, PhD

Moderator: Wengui Yu MD, PhD
Professor of Neurology, Department of Neurology, University of California Irvine, Irvine, CA

PTC Therapeutic sponsored program
Genetic Causes of Cerebral Palsy

Michael C. Kruer, MD
Barrow Neurological Institute at Phoenix Children’s hospital

AbbVie offers innovative treatments for migraine patients    

Jin Li, MD, PhD, FAAN
Associate Professor, Department of Neurology, New York Medical College, NY

Convoluted Saga in the development of anti-amyloid therapy: Do we see a light in the dark?

Jin Jun Luo, MD, PhD, FAAN
Professor of Neurology and Pharmacology, Lewis Katz Scholl of Medicine at Temple University, Philadelphia, PA

Immune Checkpoint Inhibitor related Neuromuscular complications

Ge Xiong, MD
Associate Professor, UC Davis

Moderator: Sarah Chen, MD, PhD
Associate Professor, Rutgers University-Robert Wood Johnson Medical School, New Brunswick, NJ

Debate: Telemedicine “for or against it”

Team A: in favor of telemedicine: Jin Jun Luo, MD, PhD, FAAN; Jin Li, MD, PhD, FAAN

Team B: Against telemedicine: Qing Ni, MD; William Tung MD, FAAN; Charles Wang, MD, PhD

Closing Remarks

Jin Li, MD, PhD, FAAN
Vice President of CANA
Associate Professor of Neurology, Department of Neurology, New York Medical College, New York City